LumiraDx Limited
https://www.lumiradx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From LumiraDx Limited
The Lights Are Going Out At Lumira, But Roche Is Stepping In
The struggling diagnostics company, initially valued at $5bn, has agreed to be purchased by Roche for a comparatively paltry $295m.
LumiraDX And BIVDA Speak On Challenges Of Driving Adoption Of Valuable Diagnostics
Diagnostics such as c-reactive protein tests are more sensitive than ever before, but manufacturers are still struggling to place them in primary care and community settings where they can make huge differences.
Deals Shaping The Medical Industry, July 2022
In Vivo's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2022. Data provided by Biomedtracker.
Deals Shaping The Medtech And Diagnostics Industry, July 2022
Medtech Insight's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics and Medical Devices – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in July 2022. Data provided by Biomedtracker.
Company Information
- Industry
- Biotechnology
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Molecular Diagnostics & Genetic Testing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice